Ribomunyl

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2014
02419862014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND Upper respiratory tract infection is a frequent cause of morbidity worldwide. Although the course of infection is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Ribomunyl is an immunostimulant that was developed and commercialized in the 1980s in France and has subsequently been made… (More)
Is this relevant?
2005
2005
The maturation state of (monocyte-derived) dendritic cells (DCs) determines the type of T-cell response. Currently, several… (More)
Is this relevant?
2005
2005
Monocyte-derived dendritic cells (MoDCs) in clinical use for cancer immunotherapy are ideally generated in serum-free medium (SFM… (More)
Is this relevant?
2004
2004
Dendritic cells (DC) become fully functional upon maturation by various stimuli. We tested whether an immunostimulatory effect of… (More)
Is this relevant?
2002
2002
Dendritic cells (DC) are essential for the generation of primary adaptive immune responses, but their full immunostimulatory… (More)
Is this relevant?
1997
1997
A multicenter, double-blind, placebo-controlled study was conducted to investigate the efficacy of an immunostimulant, Ribomunyl… (More)
Is this relevant?
1995
1995
Ribomunyl, an immunomodulating agent, administered to mice 24 h before irradiation, has a radioprotective effect. Ribomunyl… (More)
Is this relevant?
1993
1993
Several functions of polymorphonuclear cells (PMNs) require adhesion to occur. Various membrane proteins' functions such as CD18… (More)
Is this relevant?
1986
1986
A double blind check was conducted in two groups of patients with asthma to test ribosomal fraction (Ribomunyl) in a new tablet… (More)
Is this relevant?